About Us
Our vision
We are working toward a future where people and families living with rare diseases, especially those with few or no treatment options, have access to therapies that can transform their lives.
How we work
The programs in our late-stage rare disease pipeline originated in pharmaceutical companies where they received significant investment, but were de-prioritized for strategic reasons.
We draw on deep, trusted relationships across the pharma and biotech ecosystem to carefully select de-prioritized, de-risked assets that have potential to transform lives in rare diseases, and use our sector expertise to create win-win structures with our partners. Through rigorous scientific and commercial insights, flexible and capital-efficient execution, and close collaboration with patients, physicians and healthcare systems, we navigate complex development challenges to bring promising therapies closer to the people who need them most.
Our journey so far
-
Mereo BioPharma Group plc was founded in 2015
Our journey began back in July 2015, empowered by the recognition that there are many high-potential novel therapies that are not being progressed in pharmaceutical or biotechnology companies.
-
We acquired a portfolio of products
We acquired three quality clinical stage product candidates from Novartis in 2015 and one from AstraZeneca in 2017.
-
We merged with OncoMed
Merging with OncoMed in 2019 provided our NASDAQ listing, strengthened our balance sheet and broadened our shareholder base.
-
We signed a license and collaboration agreement with Ultragenyx
In late 2020, Mereo signed an agreement for our clinical development program in osteogenesis imperfecta with Ultragenyx, a strategic partner with expertise in rare bone diseases. Mereo retains commercial rights in Europe, while Ultragenyx holds the rights in the U.S. and rest of the world.
A purpose-led team
We understand the gravity of our work for people living with rare conditions with few therapeutic options.
Each member of our team is united by a shared passion for advancing promising therapies for rare diseases, using their unique skills, experience and perspectives. Mereo’s inclusive, collaborative culture empowers every individual to thrive and fulfill their potential.
Our team brings together leading experts in drug development, regulatory affairs, and the commercialization of therapies for rare diseases, complemented by strong financial and governance capabilities. Drawing on our collective insights and experience, we can move swiftly while maintaining a rigorous, methodical approach.
We are always looking for individuals that want to make a difference
We’re a team of passionate thinkers, collaborators, and changemakers. If you’re looking for more than a job, if you want your work to matter, Mereo is where you can make a real difference.
Our entrepreneurial spirit and purpose-led approach attracts the most talented people from across the pharmaceutical and biotechnology industry.
Join a team where your work truly matters, your voice is heard, and your impact is real.
